Clin2
NCT06241781Possibly a fitRecruiting

Immune cells from your tumor for cervical cancer

Adult

Treatments studied

Part of Cancer, Women’s health & pregnancy clinical trials.

This trial tests a new treatment using your own immune cells (called tumor-infiltrating lymphocytes) that are grown in a lab and given back to you. It is for people with cervical cancer that has come back or spread and hasn't been stopped by other treatments.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
83 people
Ages
18 years to 70 years
Study type
Interventional

Who can take part

  • You are between 18 and 70 years old.
  • You have cervical cancer that has returned or spread after at least one prior treatment.
  • You are well enough to be up and about (able to do daily activities without help).
  • You have at least one tumor that can be removed for the lab to grow immune cells, plus another area that can be seen on scans.
  • Your organs (like kidneys, liver, and bone marrow) are working well enough.
  • You are not pregnant, breastfeeding, or planning pregnancy for at least a year after treatment.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06819280Recruiting
Immune cells for advanced colorectal cancer after first treatment

This trial tests whether your own immune cells, called tumor-infiltrating lymphocytes (TILs), can be grown in a lab and given back to you to fight advanced colorectal cancer. It is for people whose cancer has continued to grow after their first round of chemotherapy.

Shanghai, Shanghai Municipality
NCT06453057Recruiting
TIL therapy for ovarian cancer

This trial tests a new therapy made from your own immune cells (called TILs) to fight ovarian cancer. Doctors remove some of your tumor, grow the immune cells in a lab, and then give them back to you to attack the cancer.

Shanghai, Shanghai Municipality
NCT05430373Recruiting· Phase 1
Injection study for advanced solid tumors using tumor-fighting cells

This Phase 1 trial tests GT101, an injection made from your own tumor-fighting immune cells, for advanced solid cancers that can’t be removed with surgery. It’s mainly aimed at checking safety and early signs of whether the treatment may work.

Beijing, Beijing Municipality
NCT06397963Recruiting
Personalized immune cell therapy for advanced solid tumors

This study tests a new treatment using your body's own immune cells (called tumor-infiltrating lymphocytes) that are taken from your tumor, grown in a lab, and then put back into you. It's for people with advanced solid tumors who have run out of standard options.

Beijing, Beijing Municipality
NCT07482319Not yet recruiting· Phase 1
Testing a new cell treatment for advanced solid tumors

This trial tests an injection of your own immune cells (tumor-infiltrating lymphocytes) to see if they can fight advanced solid tumors like stomach or lung cancer. Doctors will remove one of your tumors, grow the immune cells from it, and then give them back to you.

Beijing
NCT07266298Recruiting· Phase 1
T-cell therapy for advanced solid tumors

This trial tests a new therapy using your own immune cells, engineered to recognize and attack cancer cells. It is for people with advanced solid tumors who have no other standard treatment options.

Beijing, Beijing Municipality

Hear when a new Adult trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.